Edit |   |
---|---|
Product Name | RLY-2608 |
Description | RLY-2608 is an oral allosteric pan-mutant isoform-selective PI3K inhibitor that was discovered using MD modeling and cryo-EM to identify allosteric networks and opportunities for small molecules, followed by DEL screening. MW: 608.91 |
Size | 1 g |
Concentration | n/a |
Applications | n/a |
Other Names | n/a |
Gene, Accession, CAS # | CAS: 2733573-94-7 |
Catalog # | orb1910864 |
Price | please inquire |
Order / More Info | RLY-2608 from BIORBYT LTD. |
Product Specific References | n/a |
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558